Table 2. Liver function tests of the study population.
TSB: total serum bilirubin; AST: aspartate transaminase; ALT: alanine transaminase.
| Investigation | Range | Number of patients |
| TSB (mg/dL) | ≤1.2 | 30 (47.6%) |
| 1.3-2.0 | 19 (30.2%) | |
| 2.1-3 | 10 (15.8%) | |
| 3.1-4 | 4 (6.3%) | |
| >4 | 0 | |
| AST (U/L) | ≤40 | 37 (58.7%) |
| 41-100 | 20 (31.7%) | |
| 101-200 | 6 (9.5%) | |
| 201-300 | 0 | |
| >300 | 0 | |
| ALT (U/L) | ≤40 | 38 (60.3%) |
| 41-100 | 19 (30.1%) | |
| 101-200 | 5 (7.9%) | |
| 201-300 | 1 (1.6%) | |
| >300 | 0 |